Methylprednisolone Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Eugia US LLC with status Current. The shortage was first posted on 12/15/2021. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Eugia US LLC
- Package NDC
- 55150-313-01
- Dosage Form
- Injection
- Presentation
- Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01)
- Initial Posting
- 12/15/2021
- Revised Date
Reason
Demand increase for the drug